Literature DB >> 6755252

High-level chloroquine resistance of Plasmodium falciparum malaria acquired in Kenya.

B G Weniger, R S Blumberg, C C Campbell, T C Jones, D L Mount, S M Friedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6755252     DOI： 10.1056/NEJM198212163072506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Prevention of malaria in travellers: a growing problem.

Authors:  J S Keystone; J D MacLean
Journal:  CMAJ       Date:  1989-11-15       Impact factor: 8.262

2.  Falciparum malaria resistant to chloroquine: implications for prophylaxis.

Authors:  P Francioli; B Yersin; A Pécoud
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-12

3.  Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.

Authors:  C Herzog; C C Kibbler; C J Ellis; C V Mtawali
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-01

Review 4.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

5.  Increased accumulation of chloroquine and desethylchloroquine in homozygous sickle cells.

Authors:  A U Orjih
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.

Authors:  E Onori
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

7.  Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years.

Authors:  W Zheng; H Jiang; Z Xiong; Z Jiang; H Chen
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

8.  Relapsing malaria infection acquired in Kenya.

Authors:  J E Patterson; F J Bia; K Miller; P McPhedran
Journal:  Yale J Biol Med       Date:  1987 May-Jun

9.  AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial.

Authors:  Ousmane A Koita; Lansana Sangaré; Haiyan D Miller; Aliou Sissako; Moctar Coulibaly; Trevor A Thompson; Saharé Fongoro; Youssouf Diarra; Mamadou Ba; Ababacar Maiga; Boubakar Diallo; David M Mushatt; Frances J Mather; Jeffrey G Shaffer; Asif H Anwar; Donald J Krogstad
Journal:  Lancet Infect Dis       Date:  2017-09-12       Impact factor: 71.421
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.